Interstitial lung disease (ILD) can be associated with rheumatoid arthritis (RA) with significant morbidity and mortality. An article in The Journal of Rheumatology focused on calculating the prevalence, incidence, mortality and costs to the healthcare system of RA-related ILD (RA-ILD).1 “RA is the most common of connective tissue diseases encountered by rheumatologists—affecting about 1% of…
Systemic Sclerosis Mortality Rate May Be Underestimated
Systemic sclerosis (SSc) is a disease characterized by immunologic abnormalities, microvascular involvement and tissue fibrosis. In previous studies, 10-year survival rates ranged from 50–84%. However, there are concerns that these studies, using prevalent cohorts, are underestimating mortality. “While the prognosis of many rheumatic diseases has improved with the availability of more effective and targeted therapies,…
Mortality Rates Improve for Patients with Rheumatoid Arthritis
Emerging research suggests patients with RA are living longer, bolsters support for early aggressive treatment of RA
Improved Survival Odds Following Hip & Knee Replacements
Decreases in mortality rates following elective hip and knee replacement surgeries since 2004 may be partly due to modern surgical techniques and better pre- and post-op care.